ESCIENT PHARMACEUTICALS
Escient Pharmaceuticals is a provider of bio-technical research and development services intended to focus in advancement of first-in-class G Protein-Coupled Receptor targeted drugs. The company's services focuses on offering therapies for neuro-immuno-inflammatory and autoreactive diseases, enabling its clients to receive drugs required for treatment of serious, unserved medical needs across a broad range of therapeutic indications.
ESCIENT PHARMACEUTICALS
Industry:
Biotechnology Pharmaceutical
Founded:
2018-05-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.escientpharma.com
Total Employee:
11+
Status:
Active
Contact:
858.617.8220
Email Addresses:
[email protected]
Total Funding:
117.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Google Tag Manager WordPress Google Universal Analytics
Similar Organizations
Emendo Biotherapeutics
Emendo Biotherapeutics is a biotechnology company
Eyebiotech
Eyebiotech is a privately held ophthalmology biotechnology company.
Magpie Pharmaceuticals
Magpie Pharmaceuticals is a biotechnology company.
Current Advisors List
Current Employees Featured
Founder
Investors List
OUP (Osage University Partners)
OUP (Osage University Partners) investment in Series B - Escient Pharmaceuticals
Sanofi Ventures
Sanofi Ventures investment in Series B - Escient Pharmaceuticals
Redmile Group
Redmile Group investment in Series B - Escient Pharmaceuticals
The Column Group
The Column Group investment in Series B - Escient Pharmaceuticals
Perceptive Advisors
Perceptive Advisors investment in Series B - Escient Pharmaceuticals
Cowen Healthcare Investments
Cowen Healthcare Investments investment in Series B - Escient Pharmaceuticals
5AM Ventures
5AM Ventures investment in Series B - Escient Pharmaceuticals
The Column Group
The Column Group investment in Series A - Escient Pharmaceuticals
5AM Ventures
5AM Ventures investment in Series A - Escient Pharmaceuticals
OUP (Osage University Partners)
OUP (Osage University Partners) investment in Series A - Escient Pharmaceuticals
Key Employee Changes
| Date | New article |
|---|---|
| 2022-01-19 | Escient Pharmaceuticals Appoints Joshua Grass as New CEO |
| 2022-01-05 | Escient Pharmaceuticals Appoints Joshua Grass, MBA as CEO |
Official Site Inspections
http://www.escientpharma.com
- Host name: 109.194.224.35.bc.googleusercontent.com
- IP address: 35.224.194.109
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
More informations about "Escient Pharmaceuticals"
Leadership - Escient pharmaceuticals
Most recently, Don was a Senior Vice President in R&D at Allergan where he led an organization responsible for research and preclinical functions, clinical pharmacology, and the scientific arm …See details»
About Us - Escient pharmaceuticals
10578 Science Center Drive # 250 San Diego, CA 92121. Contact Us. © 2024 Escient Pharmaceuticals | Privacy Policy | Terms of UseSee details»
Escient Pharmaceuticals - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number 858.617.8220 Escient Pharmaceuticals is a provider of bio-technical research and development services intended to focus on the …See details»
Escient Pharmaceuticals - LinkedIn
Escient Pharmaceuticals | 2,871 followers on LinkedIn. Targeted therapeutics for neurosensory-inflammatory disorders | Escient is a clinical-stage pharmaceutical company focused on developing ...See details»
Escient Pharmaceuticals - PitchBook
Www.escientpharma.com. Formerly Known As. Mas Therapeutics. Ownership Status. Acquired/Merged (Operating Subsidiary) Financing Status. Formerly VC-backed. Corporate …See details»
Escient Pharmaceuticals Appoints Joshua Grass, MBA as CEO
Jan 5, 2022 Visit www.escientpharma.com to learn more. Contacts. Cory Tromblee Scient Public Relations [email protected]. Svetlana Makhni Escient Pharmaceuticals, Inc. …See details»
Escient Pharmaceuticals - VentureRadar
"Escient Pharmaceuticals is a biotech company that develops targeted small molecule therapeutics for a broad range of diseases. The firm's primary focus is on Mas-related G …See details»
Escient Pharmaceuticals - Craft
Escient Pharmaceuticals is a pharmaceutical company that develops therapeutics for neurosensory-inflammatory diseases. It offers solutions for patients with chronic urticaria, …See details»
Overview - Escient pharmaceuticals
We are a privately held, clinical stage biotechnology company advancing novel, differentiated therapeutics for the potential treatment of a broad range of neurosensory-inflammatory …See details»
Escient Pharmaceuticals Company Overview, Contact Details
Nov 28, 2022 Abingworth invested into Escientpharma $120M on Nov 1st '22. New Enterprise Associates, along with Boston’s Abingworth and United Kingdom’s Forge Life Sciences …See details»
Overview, News & Similar companies - ZoomInfo.com
Nov 28, 2023 Who is Escient Pharmaceuticals. Escient Pharmaceuticals is a clinical-stage, industry-leading platform biotechnology company focused on the discovery and development …See details»
Escient Pharmaceuticals Announces $120 Million Series C Financing
Nov 28, 2022 Aaron Mishel Chief Financial Officer Escient Pharmaceuticals, Inc. [email protected]. Contacts. Aaron Mishel Chief Financial Officer Escient …See details»
Escient Pharmaceuticals Announces IND Clearance by FDA
Jan 30, 2023 Aaron Mishel Chief Financial Officer Escient Pharmaceuticals, Inc. [email protected]. Contacts. Aaron Mishel Chief Financial Officer Escient …See details»
Incyte Announces Acquisition of Escient Pharmaceuticals and its ...
Apr 23, 2024 EP262, a first-in-class oral Mas-related G protein-coupled receptor X2 (MRGPRX2) antagonist with the potential to treat a broad range of inflammatory disorders, has …See details»
Science - Escient pharmaceuticals
10578 Science Center Drive # 250 San Diego, CA 92121. Contact Us. © 2024 Escient Pharmaceuticals | Privacy Policy | Terms of UseSee details»
Join our Team - Escient pharmaceuticals
Open Positions Escient is always looking for passionate and talented individuals to join our team. Please explore our open positions below. View our currently open positions. Job listings …See details»
Escient Pharmaceuticals Initiates Clinical Proof-of-Concept Study …
Nov 28, 2023 Aaron Mishel Chief Financial Officer Escient Pharmaceuticals, Inc. [email protected]. Contacts. Aaron Mishel Chief Financial Officer Escient …See details»
Incyte Corporation Inks Deal to Acquire Escient Pharmaceuticals …
Apr 24, 2024 Incyte Corporation announced that it has agreed to terms on the acquisition of Escient Pharmaceuticals, which includes the promising drug candidates EP262 and EP547.See details»
Press Releases - Escient pharmaceuticals
May 30, 2024 April 23, 2024 Incyte Announces Acquisition of Escient Pharmaceuticals and its Pipeline of First-in-Class Oral MRGPR Antagonists. WILMINGTON, Del. and SAN DIEGO, …See details»